Serum long non‑coding RNA NNT‑AS1 protected by exosome is a potential biomarker and functions as an oncogene via the miR‑496/RAP2C axis in colorectal cancer

Yin,Hua; Hu,Jingjing; Ye,Zhiying; Chen,Saijun; Chen,Yunwen

doi:10.3892/mmr.2021.12224

Serum long non‑coding RNA NNT‑AS1 protected by exosome is a potential biomarker and functions as an oncogene via the miR‑496/RAP2C axis in colorectal cancer

Authors:
- Hua Yin
- Jingjing Hu
- Zhiying Ye
- Saijun Chen
- Yunwen Chen
View Affiliations

Affiliations: Department of B‑Ultrasonic Room, Hwamei Hospital, University of Chinese Academy of Sciences, Ningbo, Zhejiang 315010, P.R. China
Published online on: June 15, 2021 https://doi.org/10.3892/mmr.2021.12224
Article Number: 585
Copyright: © Yin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Increasing evidence has indicated that long non‑coding RNAs (lncRNAs) serve an essential role in carcinogenesis and cancer development. It has been reported that lncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 (NNT‑AS1) serves a crucial role in several types of cancer. However, the clinical significance of circulating NNT‑AS1 expression in colorectal cancer (CRC) remains to be elucidated. The current study aimed to investigate the potential role of NNT‑AS1 and the clinical significance of its serum expression levels in patients with CRC. The expression of NNT‑AS1 was measured in 40 pairs of tumor and adjacent normal tissues from patients with CRC via reverse transcription‑quantitative PCR. The serum expression levels of NNT‑AS1 were assayed in an independent cohort of healthy controls and patients with CRC. The levels of NNT‑AS1 were also compared between paired preoperative and postoperative serum samples. In addition, the presence of exosomal NNT‑AS1 in serum was explored. Furthermore, the biological roles of NNT‑AS1 were investigated in CRC cells in vitro. The expression of NNT‑AS1 was significantly upregulated in tumor tissues compared with adjacent normal tissues (P<0.05). A higher level of NNT‑AS1 was associated with an advanced CRC stage. The serum levels of NNT‑AS1 were significantly upregulated in patients with CRC compared with healthy subjects (P<0.05). Furthermore, the NNT‑AS1 levels were significantly decreased in postoperative samples compared with preoperative samples (P<0.01). In addition, it was also identified that NNT‑AS1 was upregulated in CRC exosomes (P<0.01), whereas no significant difference was observed in NNT‑AS1 levels between serum and exosomes. Silencing of NNT‑AS1 inhibited the proliferation, migration and invasion of CRC cells. It was also identified that NNT‑AS1 exerted its effects via regulation of the microRNA‑496/Ras‑related protein Rap‑2c axis. The present study demonstrated that circulating NNT‑AS1, which may be protected by exosomes, could be a novel potential biomarker and therapeutic target in CRC.

View Figures

View References

1	Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics, 2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
2	Brenner H, Kloor M and Pox CP: Colorectal cancer. Lancet. 383:1490–1502. 2014. View Article : Google Scholar : PubMed/NCBI
3	The Lancet: Toward better control of colorectal cancer. Lancet. 383:14372014. View Article : Google Scholar : PubMed/NCBI
4	Peng WX, Koirala P and Mo YY: LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI
5	Wang KC and Chang HY: Molecular mechanisms of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
6	Han D, Wang M, Ma N, Xu Y, Jiang Y and Gao X: Long noncoding RNAs: Novel players in colorectal cancer. Cancer Lett. 361:13–21. 2015. View Article : Google Scholar : PubMed/NCBI
7	Schmitt AM and Chang HY: Long noncoding RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
8	Hua F, Liu S, Zhu L, Ma N, Jiang S and Yang J: Highly expressed long non-coding RNA NNT-AS1 promotes cell proliferation and invasion through Wnt/β-catenin signaling pathway in cervical cancer. Biomed Pharmacother. 92:1128–1134. 2017. View Article : Google Scholar : PubMed/NCBI
9	Huang Q, Wang S, Li X, Yang F, Feng C, Zhong K, Qiu M and Wang J: Circular RNA ATXN7 is upregulated in non-small cell lung cancer and promotes disease progression. Oncol Lett. 17:4803–4810. 2019.PubMed/NCBI
10	Wang L, Ma H, Kong W, Liu B and Zhang X: Up-regulated circular RNA VANGL1 contributes to progression of non-small cell lung cancer through inhibition of miR-195 and activation of Bcl-2. Biosci Rep. 39:BSR201824332019. View Article : Google Scholar : PubMed/NCBI
11	He W, Zhang Y and Xia S: LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis. Thorac Cancer. 11:549–560. 2020. View Article : Google Scholar : PubMed/NCBI
12	Wang Q, Yang L, Hu X, Jiang Y, Hu Y, Liu Z, Liu J, Wen T, Ma Y, An G and Feng G: Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo. Oncotarget. 8:3441–3453. 2017. View Article : Google Scholar : PubMed/NCBI
13	Sun T, Kalionis B, Lv G, Xia S and Gao W: Role of exosomal noncoding RNAs in lung carcinogenesis. Biomed Res Int. 2015:1258072015. View Article : Google Scholar : PubMed/NCBI
14	Gallo A, Tandon M, Alevizos I and Illei GG: The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One. 7:e306792012. View Article : Google Scholar : PubMed/NCBI
15	Luga V, Zhang L, Viloria-Petit AM, Ogunjimi AA, Inanlou MR, Chiu E, Buchanan M, Hosein AN, Basik M and Wrana JL: Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell. 151:1542–1556. 2012. View Article : Google Scholar : PubMed/NCBI
16	Hewson C and Morris KV: Form and function of exosome-associated long non-coding RNAs in cancer. Curr Top Microbiol Immunol. 394:41–56. 2016.PubMed/NCBI
17	Lee YS and Dutta A: MicroRNAs in cancer. Annu Rev Pathol. 4:199–227. 2009. View Article : Google Scholar : PubMed/NCBI
18	Ma R, Zhu P, Liu S, Gao B and Wang W: MiR-496 suppress tumorigenesis via targeting BDNF-mediated PI3K/Akt signaling pathway in non-small cell lung cancer. Biochem Biophys Res Commun. 518:273–277. 2019. View Article : Google Scholar : PubMed/NCBI
19	Alvarado S, Wyglinski J, Suderman M, Andrews SA and Szyf M: Methylated DNA binding domain protein 2 (MBD2) coordinately silences gene expression through activation of the microRNA hsa-mir-496 promoter in breast cancer cell line. PLoS One. 8:e740092013. View Article : Google Scholar : PubMed/NCBI
20	Wu J, Du W, Wang X, Wei L, Pan Y, Wu X, Zhang J and Pei D: Ras-related protein Rap2c promotes the migration and invasion of human osteosarcoma cells. Oncol Lett. 15:5352–5358. 2018.PubMed/NCBI
21	Zhu X, Qiu J, Zhang T, Yang Y, Guo S, Li T, Jiang K, Zahoor A, Deng G and Qiu C: MicroRNA-188-5p promotes apoptosis and inhibits cell proliferation of breast cancer cells via the MAPK signaling pathway by targeting Rap2c. J Cell Physiol. 235:2389–2402. 2020. View Article : Google Scholar : PubMed/NCBI
22	Wang Z, Huang C, Zhang A, Lu C and Liu L: Overexpression of circRNA_100290 promotes the progression of laryngeal squamous cell carcinoma through the miR-136-5p/RAP2C axis. Biomed Pharmacother. 125:1098742020. View Article : Google Scholar : PubMed/NCBI
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
24	Yu R, Yu BX, Chen JF, Lv XY, Yan ZJ, Cheng Y and Ma Q: Anti-tumor effects of Atractylenolide I on bladder cancer cells. J Exp Clin Cancer Res. 35:402016. View Article : Google Scholar : PubMed/NCBI
25	Muschelli J: ROC and AUC with a binary predictor: Potentially a misleading metric. J Classif. 37:696–708. 2002. View Article : Google Scholar : PubMed/NCBI
26	Li C, Zhang S, Qiu T, Wang Y, Ricketts DM and Qi C: Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a. Cancer Biol Ther. 20:413–422. 2019. View Article : Google Scholar : PubMed/NCBI
27	Li T, Ding ZL, Zheng YL and Wang W: MiR-484 promotes non-small-cell lung cancer (NSCLC) progression through inhibiting Apaf-1 associated with the suppression of apoptosis. Biomed Pharmacother. 96:153–164. 2017. View Article : Google Scholar : PubMed/NCBI
28	Wang L, Duan W, Yan S, Xie Y and Wang C: Circulating long non-coding RNA colon cancer-associated transcript 2 protected by exosome as a potential biomarker for colorectal cancer. Biomed Pharmacother. 113:1087582019. View Article : Google Scholar : PubMed/NCBI
29	Lu YB, Jiang Q, Yang MY, Zhou JX and Zhang Q: Long noncoding RNA NNT-AS1 promotes hepatocellular carcinoma progression and metastasis through miR-363/CDK6 axis. Oncotarget. 8:88804–88814. 2017. View Article : Google Scholar : PubMed/NCBI
30	Huang Y, Shi J and Xu Y: Long non-coding RNA NNT-AS1 contributes to cell proliferation, metastasis and apoptosis in human ovarian cancer. Oncol Lett. 15:9264–9270. 2018.PubMed/NCBI
31	Abedini P, Fattahi A, Agah S, Talebi A, Beygi AH, Amini SM, Mirzaei A and Akbari A: Expression analysis of circulating plasma long noncoding RNAs in colorectal cancer: The relevance of lncRNAs ATB and CCAT1 as potential clinical hallmarks. J Cell Physiol. 234:22028–22033. 2019. View Article : Google Scholar : PubMed/NCBI
32	Zhang R, Xia Y, Wang Z, Zheng J, Chen Y, Li X, Wang Y and Ming H: Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer. Biochem Biophys Res Commun. 490:406–414. 2017. View Article : Google Scholar : PubMed/NCBI
33	Shen J, Hodges TR, Song R, Gong Y, Calin GA, Heimberger AB and Zhao H: Serum HOTAIR and GAS5 levels as predictors of survival in patients with glioblastoma. Mol Carcinog. 57:137–141. 2018. View Article : Google Scholar : PubMed/NCBI
34	Arita T, Ichikawa D, Konishi H, Komatsu S, Shiozaki A, Shoda K, Kawaguchi T, Hirajima S, Nagata H, Kubota T, et al: Circulating long non-coding RNAs in plasma of patients with gastric cancer. Anticancer Res. 33:3185–3193. 2013.PubMed/NCBI
35	Niu L, Song X, Wang N, Xue L, Song X and Xie L: Tumor-derived exosomal proteins as diagnostic biomarkers in non-small cell lung cancer. Cancer Sci. 110:433–442. 2019. View Article : Google Scholar : PubMed/NCBI
36	Pant S, Hilton H and Burczynski ME: The multifaceted exosome: Biogenesis, role in normal and aberrant cellular function and frontiers for pharmacological and biomarker opportunities. Biochem Pharmacol. 83:1484–1494. 2012. View Article : Google Scholar : PubMed/NCBI
37	Zhou R, Chen KK, Zhang J, Xiao B, Huang Z, Ju C, Sun J, Zhang F, Lv XB and Huang G: The decade of exosomal long RNA species: An emerging cancer antagonist. Mol Cancer. 17:752018. View Article : Google Scholar : PubMed/NCBI
38	Liu T, Zhang X, Gao S, Jing F, Yang Y, Du L, Zheng G, Li P, Li C and Wang C: Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer. Oncotarget. 7:85551–85563. 2016. View Article : Google Scholar : PubMed/NCBI
39	Qi NN, Tian S, Li X, Wang FL and Liu B: Up-regulation of microRNA-496 suppresses proliferation, invasion, migration and in vivo tumorigenicity of human osteosarcoma cells by targeting eIF4E. Biochimie. 163:1–11. 2019. View Article : Google Scholar : PubMed/NCBI
40	Ye J, Xie W, Zuo Y, Jing G and Tong J: MicroRNA-496 suppresses tumor cell proliferation by targeting BDNF in osteosarcoma. Exp Ther Med. 19:1425–1431. 2020.PubMed/NCBI
41	Wang H, Yan B, Zhang P, Liu S, Li Q, Yang J, Yang F and Chen E: MiR-496 promotes migration and epithelial-mesenchymal transition by targeting RASSF6 in colorectal cancer. J Cell Physiol. 235:1469–1479. 2020. View Article : Google Scholar : PubMed/NCBI